FeedworthyAI
Back to feed
GEN – Genetic Engineering and Biotechnology Newsnews

Biopharma Hungry for GLP-1 Receptor Agonist Manufacturing Skills

Wednesday, July 29, 2026Corinna Singleman, PhDView original

NIBRT predicts that the market for GLP-1 receptor agonist-based diabetes and obesity meds will increase demand for biopharmaceutical engineers with a mix of synthetic chemistry and biotech skills.

The post Biopharma Hungry for GLP-1 Receptor Agonist Manufacturing Skills appeared first on GEN - Genetic Engineering and Biotechnology News.